Description of the psychopharmacological medication agent, including brand and generic names, as well as appropriate FDA indication uses
Any supporting, valid, and reliable research for non-FDA uses
Drug classification
The medication mechanism of action
The medication pharmacokinetics
The medication pharmacodynamics
Appropriate dosing, administration route, and any considerations for dosing alterations
Considerations of use and dosing in specific specialty populations, such as children, adolescents, elderly, pregnant people, those exhibiting suicidal behaviors, etc.
Definition of half-life, why half-life is important, and the half-life for your assigned medication
Side effects/adverse reactions potential
Discuss clinical concerns with EPS and Tardive Dyskinesia
Note: Be sure to include screening tools that would be utilized.
Contraindications for use including significant drug to drug interactions
Overdose considerations
Diagnostics and labs monitoring comorbidities considerations
Legal, ethical, and social considerations
Pertinent patient education considerations